Derniers essais


EudraCT Number: 2022-003922-27 Sponsor Protocol Number: PAM-UMCG-002 Start Date: 2024-02-08
Sponsor Name: University Medical Center Groningen (UMCG)
Full Title: Neo-adjuvant Pembrolizumab as alternative to radio(chemo)therapy in MMRd uterine cancer
Medical condition: Primary uterine cancer characterized with dMMR
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2022-004238-20 Sponsor Protocol Number: CC21000 Start Date: 2024-02-06
Sponsor Name: Vejle Hospital
Full Title: BONG: Breathlessness and alternatives to Opioid treatment in Non-malign Groups of severe lung disease
Medical condition: COPD
Disease: Version SOC Term Classification Code Term Level
21.1 10042613 - Surgical and medical procedures 10075530 Medical cannabis therapy PT
21.1 10038738 - Respiratory, thoracic and mediastinal disorders 10010952 COPD LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DK (Trial now transitioned)
Trial results: (No results available)
EudraCT Number: 2013-000356-18 Sponsor Protocol Number: 25051974 Start Date: 2023-12-21
Sponsor Name: Stichting Apotheek der Haarlemse Ziekenhuizen
Full Title: Effect of repeated intranasal cobalamin administration on cobalamin deficiency in elderly
Medical condition: Cobalamin (vitamin B12) deficiency
Disease: Version SOC Term Classification Code Term Level
Population Age: Elderly Gender: Male, Female
Trial protocol: NL (Completed)
Trial results: (No results available)

EudraCT Number: 2020-003146-36 Sponsor Protocol Number: RIAlta-1 Start Date: 2023-11-15
Sponsor Name: Vall d'Hebron Research Institute (VHIR)
Full Title: Safety of Rifampicin at High Dose for the Treatment of Adult Subjects with Complex Drug Susceptible Pulmonary and Extrapulmonary Tuberculosis
Medical condition: Pulmonary and extrapulmonary tuberculosis
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: NL (Ongoing) ES (Ongoing)
Trial results: (No results available)
EudraCT Number: 2020-003804-15 Sponsor Protocol Number: SGMCBM Start Date: 2023-11-09
Sponsor Name: Leiden University Medical Center
Full Title: A FEASIBILITY STUDY OF SGM-101, A FLUOROCHROME-LABELED ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY FOR THE INTRAOPERATIVE DETECTION OF COLORECTAL BRAIN METASTASES
Medical condition: Colorectal brain metastases
Disease: Version SOC Term Classification Code Term Level
21.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10052358 Colorectal cancer metastatic PT
21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10055093 Brain cancer metastatic PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2022-001632-28 Sponsor Protocol Number: GENTLE Start Date: 2023-10-24
Sponsor Name: Rijnstate
Full Title: Ghrelin in anterior circulation stroke and EVT
Medical condition: acute ischemic stroke
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2022-003318-35 Sponsor Protocol Number: VX22-264-101 Start Date: 2023-09-25
Sponsor Name: Vertex Pharmaceuticals Incorporated
Full Title: A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-264 in Subjects With Type 1 Diabetes Mellitus
Medical condition: Type 1 Diabetes Mellitus
Disease: Version SOC Term Classification Code Term Level
20.0 10027433 - Metabolism and nutrition disorders 10012601 Diabetes mellitus PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Ongoing) NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2022-001287-10 Sponsor Protocol Number: NBK241/2/2022 Start Date: 2023-09-22
Sponsor Name: Gdański Uniwersytet Medyczny
Full Title: Treatment of acute ischemic stroke due to occlusion of a large vessel by mechanical thrombectomy in patients with unknown onset or not meeting the criteria for CT eligibility (ASPECTS
Medical condition: acute ischemic stroke caused by occlusion of a large vessel
Disease: Version SOC Term Classification Code Term Level
23.1 10029205 - Nervous system disorders 10084836 Malignant ischemic stroke LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: PL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2022-002839-66 Sponsor Protocol Number: IMVT-1401-3203 Start Date: 2023-09-07
Sponsor Name: Immunovant Sciences, GmbH
Full Title: An Open-label Extension Study for Participants who Completed Study IMVT-1401-3201 or Study IMVT-1401-3202 to Assess the Efficacy and Safety of Batoclimab for the Treatment of Thyroid Eye Disease (TED)
Medical condition: Thyroid Eye Disease (TED)
Disease: Version SOC Term Classification Code Term Level
23.1 100000004853 10084358 Thyroid eye disease LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Not Authorised) LV (Ongoing) BE (Trial now transitioned) HU (Ongoing) SK (Trial now transitioned) IT (Ongoing) ES (Ongoing) PL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2022-001021-74 Sponsor Protocol Number: HBI-3000-402 Start Date: 2023-08-30
Sponsor Name: HUYABIO International, LLC
Full Title: A Phase 2, Two-Stage, Serial Cohort Dose Escalation and Expansion Study of a Single Intravenous Infusion of HBI-3000 for the Conversion of Atrial Fibrillation (AF) of Recent Onset
Medical condition: Sustained atrial fibrillation (AF) of over 2 hours and
Disease: Version SOC Term Classification Code Term Level
20.0 10007541 - Cardiac disorders 10003658 Atrial fibrillation PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: PL (Completed)
Trial results: (No results available)
3
S'abonner